Company: STAA
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058174
Chunk: 18

Company: STAAR SURGICAL CO
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 18
---
’s Compensation Committee and Board of Directors have analyzed and continue to monitor whether STAAR’s compensation practices with respect to executive officers or any of its employees create incentives for risk-taking that could harm STAAR or its business. The Compensation Committee and the Board of Directors have determined that STAAR’s compensation practices and policies do not create any risk that is reasonably likely to have a material adverse effect on STAAR.

Meetings of the Board of Directors

The Board held 11 meetings during 2024. During 2024, each of our directors attended more than 75% of the total number of meetings of the Board and Board Committees on which they then served (during the period he or she served). In addition to Board meetings, directors are kept informed of our business through personal meetings and other communications, including telephone and electronic contacts with our Chief Executive Officer and others regarding matters of interest and concern to us and our shareholders. Independent directors meet when they deem necessary in executive session without management and at such other times as may be requested by any independent director. It is the policy of STAAR that directors attend the annual meeting of shareholders, if practicable. Each of our director nominees who was serving on our Board at the time of the 2024 Annual Meeting attended the 2024 Annual Meeting.

Board Committee Structure and Composition

The Board has three standing committees: an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee. The Board has adopted a written charter for each Board Committee to provide for its organization, procedures, and responsibilities.

| 2025 Proxy Statement | – 13 – |

#### ––Corporate Governance––
The following chart reflects the composition of the Board’s three standing committees as of the date of this Proxy Statement:

| Committee Composition                           |        |              |                           |
|                                                 | Audit  | Compensation | Nominating and Governance |
| Arthur C. Butcher                               | —      | Chair        | —                         |
| Stephen C. Farrell*                             | —      | —            | —                         |
| Wei Jiang                                       | —      | —            | —                         |
| Louis E. Silverman                              | Member | —            | Member                    |
| Elizabeth Yeu, M.D.**                           | Member | Member       | Chair                     |
| Lilian Y. Zhou                                  | Chair  | Member       | Member                    |
| *   Chief Executive Officer      ** Board Chair |        |              |                           |

Nominating and Governance Committee The principal purpose of the Nominating and Governance Committee is